Evidence map›Paper›PMID 22614018›Full record

ArticleOncogene2013

Promotion of DNA repair by nuclear IKKβ phosphorylation of ATM in response to genotoxic stimuli.

K Sakamoto, Y Hikiba, H Nakagawa, Y Hirata, Y Hayakawa, H Kinoshita, W Nakata, K Sakitani, R Takahashi, M Akanuma and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Role of HOXC10 in Cancer.Frontiers in oncology · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. New approaches to radiation protection.Frontiers in oncology · 2014
    Review
  16. Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB.Apoptosis : an international journal on programmed cell death · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

K SakamotoDivision of Gastroenterology, Institute for Adult Diseases, Asahi Life Foundation, Tokyo, Japan.
Y Hikiba
H Nakagawa
Y Hirata
Y Hayakawa
H Kinoshita
W Nakata
K Sakitani
R Takahashi
M Akanuma
H Kamata
S Maeda

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ataxia-telangiectasia mutated (ATM) is one of the key molecules involved in the cellular response to DNA damage. A portion of activated ATM is exported from the nucleus into the cytoplasm, where it activates the I kappa B kinase/nuclear factor kappa B (IKK/NF-κB) signaling pathway. It has been thought that activated IKKβ, which is a critical kinase for NF-κB activation, generally resides in the cytoplasm and phosphorylates cytoplasmic downstream molecules, such as IκBα. Here, we identified a new role for IKKβ during the response to DNA damage. ATM phosphorylation in response to alkylating agents consisted of two phases: the early phase (up to 3 h) and late phase (after 6 h). A portion of the activated IKKβ generated during the DNA damage response was found to translocate into the nucleus and directly phosphorylate ATM in the late phase. Furthermore, the phosphorylation of ATM by nuclear IKKβ was suggested to promote DNA repair. In parallel, activated IKKβ induced classical NF-κB activation and was involved in anti-apoptosis. Our findings define the function of IKKβ during the response to DNA damage, which promotes cell survival and DNA repair, and maintains cellular homeostasis.

Indexed as

DNA DamageAnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell NucleusCells, CulturedChlorocebus aethiopsComet AssayCOS CellsCytoplasmDNA-Binding ProteinsDNA RepairGene Expression Regulation, NeoplasticHeLa CellsHumansI-kappa B KinaseAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Binding ProteinsI-kappa B KinaseNF-kappa BProtein Serine-Threonine KinasesRNA, Small InterferingTumor Suppressor Proteins

Identifiers

PMID22614018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.